Ambu A/S (OTCMKTS:AMBBY) Sets New 52-Week Low – Here’s Why

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $9.51 and last traded at $9.51, with a volume of 415 shares changing hands. The stock had previously closed at $9.70.

Ambu A/S Price Performance

The firm has a market cap of $2.01 billion, a price-to-earnings ratio of 30.52 and a beta of 0.98. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.73 and a current ratio of 2.92. The business has a 50 day simple moving average of $10.09 and a 200-day simple moving average of $11.70.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.07 EPS for the quarter. Ambu A/S had a return on equity of 8.03% and a net margin of 7.81%.The firm had revenue of $246.39 million during the quarter.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.